Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension READ MORE
Aspargo Laboratories Announces IND Clearance by U.S. FDA, Enabling Launch of Bioequivalence and Food-Effect Studies for Sildenafil Oral Spray READ MORE
Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application For Sildenafil Oral Spray READ MORE
Aspargo Receives Regulatory Approval to Market Sildenafil Spray in Germany, Ireland, and The Netherlands READ MORE
Aspargo Extends Latin America Reach From Mexico To Argentina READ MORE
Aspargo’s Footprint Grows With Middle East Expansion READ MORE
Aspargo Expands Beyond Spain Into Latin America READ MORE
Aspargo Acquires Bandol® Sildenafil Spray READ MORE
Aspargo Acquires International Rights to Sildenafil Oral Spray READ MORE
Aspargo Announces Successful Completion of Pre-IND Meeting w/ FDA READ MORE